Primary Aldosteronism, Aldosterone, and Extracellular Vesicles

Endocrinology. 2022 Jan 1;163(1):bqab240. doi: 10.1210/endocr/bqab240.

Abstract

Primary aldosteronism (PA) is an endocrine related condition leading to arterial hypertension due to inappropriately high and unregulated aldosterone concentration. Recently, a broad spectrum of PA has been recognized, which brings new challenges associated with early identification of this condition that affect renal epithelial and extrarenal tissues. Reports have shown the potential role of extracellular vesicles (EVs) and EV cargo as novel and complementary biomarkers in diagnosis and prognosis of PA. In vivo and in vitro studies have identified specific EV surface antigens, EV-proteins, and EV microRNAs that can be useful to develop novel diagnostic algorithms to detect, confirm, or follow up the PA. Moreover, the study of EVs in the field of PA provides further insight in the pathophysiological mechanism of the PA disease.

Keywords: aldosterone; biomarkers; extracellular vesicles; primary aldosteronism.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Aldosterone / metabolism*
  • Biomarkers / metabolism*
  • Extracellular Vesicles / genetics
  • Extracellular Vesicles / metabolism*
  • Gene Expression Regulation
  • Humans
  • Hyperaldosteronism / diagnosis*
  • Hyperaldosteronism / genetics
  • Hyperaldosteronism / metabolism
  • Hypertension / diagnosis
  • Hypertension / genetics
  • Hypertension / metabolism
  • MicroRNAs / genetics*
  • Prognosis
  • Renin / metabolism

Substances

  • Biomarkers
  • MicroRNAs
  • Aldosterone
  • Renin